CJC-1295 DAC (5mg) FAST DELIVERY TO AUSTRALIA SKYBLUE INTERNATIONAL is a trusted global pharmaceutical export company specializing in the export of high-quality medicines. With a strong commitment to healthcare excellence, we supply a wide range of branded and generic medicines to countries including the USA, UK, Australia, UAE, Canada, Singapore, and the Philippines. Our focus is on reliability, compliance, and timely delivery to meet the global demand for affordable and effective medical solutions. Medicine 💊 USES : CJC-1295 DAC (Drug Affinity Complex) is a long-acting growth hormone-releasing hormone (GHRH) analog designed to elevate IGF-1 and growth hormone (GH) levels for days after a single injection. Below is a detailed breakdown of its primary applications, mechanisms, and protocols. Fat Loss & Metabolism Boosts lipolysis (fat breakdown), especially stubborn visceral fat. Improves insulin sensitivity → Supports metabolic health. Mechanism: Binds to GHRH receptors in the pituitary → sustained GH release (elevates IGF-1 for 5-7 days per dose). Half-life: 6-8 days (due to DAC modification, which prevents rapid breakdown). Key Difference vs. CJC-1295 (no DAC): CJC-1295 DAC → Long-lasting effects (fewer injections needed). Standard CJC-1295 → Shorter duration (requires daily dosing). Standard Protocol (5mg Vial) Reconstitution: Mix with 2mL bacteriostatic water (yields 2.5mg/mL). Dosing: Beginner: 1mg (0.4mL) 2x/week (e.g., Monday & Thursday). Advanced: 2mg (0.8mL) 2x/week (for maximum IGF-1 elevation). Cycle Length: 8-12 weeks (followed by a 4-week break). ✅ Best for: Athletes wanting sustained muscle growth & recovery. Men/women targeting fat loss + anti-aging benefits. Those who prefer fewer injections (vs. daily peptides). WE EXPORT IN UK WE EXPORT IN SINGAPORE WE EXPORT IN DUBAI WE EXPORT IN JAPAN WE EXPORT IN CANADA

The first 29 amino acids of GHRH were discovered to be as equally potent as its full 44 amino acid structure[1][2] This fragment became known as GRF (1-29). However, due to a rapid metabolic clearance analogues of GRF (1-29) were synthesized to enhance the biological activity and reduce the rapidity of metabolic clearance. These analogues were primarily created by substituting amino acids within the peptide structure for amino acids more resistant to enzymatic cleavage. One early analogue substituted the amino acid L-alanine (abbreviated as Ala or A) at the 2nd position of the peptide structure for its optical isomer (mirror image), D-alanine (abbreviated as D-Ala). This substitution resulted in a peptide bond between D-Ala and the 3rd amino acid in the structure aspartic acid (Asp) more able to resist rapid cleavage by the enzyme dipeptidyl peptidase-4, a cleavage which had previously led to an inactive peptide fragment.[3][4] This successful modification prompted the further creation of analogues with additional amino acid substitutions. Ipamorelin: A selective growth hormone secretagogue, Ipamorelin stimulates the release of GH by mimicking ghrelin's action on the ghrelin receptor. It is known for its specificity and minimal side effects compared to other GH-releasing peptides. Mod GRF 1-29 (CJC-1295 without DAC): This is a modified version of the first 29 amino acids of growth hormone-releasing hormone (GHRH). The modifications extend its half-life and enhance its ability to stimulate the pituitary gland to release GH. It is often used in research to study GH secretion patterns and related metabolic effects. ⚖️ Dosage and Composition The 5/5 mg blend indicates that each vial contains 5 mg of Mod GRF 1-29 and 5 mg of Ipamorelin, totaling 10 mg per vial. This combination is designed to provide a balanced stimulation of GH release, potentially offering synergistic effects when used in research protocols. 🔬 Research Applications In scientific studies, this peptide blend is utilized to: Study Growth Hormone Dynamics: Investigating the patterns and regulation of GH secretion. Metabolic Research: Understanding the role of GH in metabolism, including fat metabolism and muscle growth. Aging and Longevity Studies: Exploring the effects of GH on aging processes and potential therapeutic applications. Sleep and Recovery Research: Examining how GH influences sleep patterns and recovery processes. ⚠️ Important Considerations Research Use Only: These peptides are intended strictly for laboratory research and are not approved for human or veterinary use. Legal Status: The legality of purchasing and possessing these peptides varies by country and jurisdiction. It's essential to consult local regulations before acquiring them. Storage and Handling: Proper storage conditions are crucial to maintain peptide stability. Typically, lyophilized peptides should be stored at -20°C or colder and protected from light. Reconstitution should be done with appropriate solvents, and solutions should be stored at 4°C and used within a specified timeframe. Mod GRF 1-29 + Ipamorelin (5/5 mg) is primarily used in scientific research and clinical studies to investigate its effects on human growth hormone (GH) release and related metabolic functions. It is not FDA-approved for general medical use, but here are the commonly researched uses and potential applications: Stimulation of Growth Hormone (GH) Release Both peptides work synergistically to enhance the natural pulsatile release of GH from the pituitary gland. Mod GRF 1-29 initiates GH release, while Ipamorelin amplifies it by mimicking ghrelin. Anti-Aging Studies GH has regenerative effects on tissues, so researchers study this combo to explore its potential for: Improving skin elasticity Increasing energy levels Enhancing sleep quality Muscle Growth and Recovery (in studies) GH can help stimulate muscle protein synthesis and recovery. This combo is sometimes researched for its effects on lean muscle mass and exercise recovery. Fat Loss & Metabolic Support GH mobilizes stored fat, making this blend of interest in obesity and metabolic syndrome research. May support lipolysis (fat breakdown) in clinical models. Bone Density Studies GH supports bone mineralization. This combo is explored for potential applications in osteopenia/osteoporosis research. Sleep Improvement GH release is tied to deep sleep stages; researchers observe whether this combo improves sleep architecture and REM sleep. Modified GRF (1-29) acts to increase growth hormone production and release by binding to the growth-hormone-releasing hormone receptor (GHRHR) on cells in the anterior pituitary.

Tesamorelin injection is a hormone similar to the one normally released from the hypothalamus gland in the brain. It is used to reduce excess fat (lipodystrophy) in the stomach area in patients with human immunodeficiency virus (HIV) infection. Tesamorelin + Ipamorelin (6mg/2mg) Blend: Medical Uses & Applications This peptide combination is primarily used for metabolic, anti-aging, and body composition benefits. Here’s a breakdown of its primary medical and off-label uses: 1. Approved Medical Use (FDA-Approved for HIV Lipodystrophy) ✅ Tesamorelin (6mg) FDA-approved to treat HIV-associated lipodystrophy (excess belly fat caused by antiretroviral therapy). Mechanism: Stimulates growth hormone (GH) release, reducing visceral fat. 2. Off-Label & Research-Based Uses A. Fat Loss & Metabolic Health Visceral fat reduction (even in non-HIV patients). Improves insulin sensitivity (potential for metabolic syndrome/type 2 diabetes support). B. Muscle Growth & Recovery Ipamorelin (2mg) is a growth hormone secretagogue (GHS) that: Boosts lean muscle mass. Enhances post-workout recovery. C. Anti-Aging & Longevity Increases collagen production (improves skin elasticity). May support cognitive function (GH plays a role in brain health). D. Injury & Tissue Repair Accelerates healing of tendons/ligaments (used by athletes). 3. Typical Treatment Protocol Dosage: Tesamorelin: 1-2mg/day (often 6mg total per week). Ipamorelin: 200-300mcg/day (2mg total per week). Administration: Subcutaneous injections (stomach or thigh). Cycle Length: 8-12 weeks (with breaks to avoid GH desensitization). 4. Key Benefits vs. Other Peptides Peptide Primary Use Pros Cons Tesamorelin FDA-approved fat loss Targets stubborn belly fat Expensive, requires prescri Final Verdict This blend is best for: ✔ Men/women targeting stubborn fat (especially abdominal). ✔ Athletes seeking muscle recovery & anti-aging benefits. ✔ Those wanting a safer alternative to synthetic GH. 4. Typical Dosage & Protocol Tesamorelin: 1-2mg/day (or 6mg/week). Ipamorelin: 200-300mcg/day (or 2mg/week). Administration: Subcutaneous injection (stomach/thigh). Cycle Length: 8-12 weeks (followed by a break to avoid GH resistance). 3. How It Works Tesamorelin → Stimulates pituitary GH release → Reduces visceral fat. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. 5. Expected Results & Timeline 📌 4-6 Weeks: Reduced belly fat, improved energy. 📌 8-12 Weeks: Visible muscle definition, better skin elasticity. 📌 Beyond 3 Months: Enhanced recovery, potential cognitive benefits. (Best when combined with diet + exercise) . Rare (serious): Increased blood sugar (caution for diabetics). Carpal tunnel syndrome (high doses). Final Verdict ✅ Best for: Men/women struggling with belly fat. Athletes seeking muscle recovery + anti-aging. Those wanting GH benefits without synthetic HGH risks. ❌ Not for: Quick fixes – requires consistent use for 2-3 months Tesamorelin, known for reducing abdominal fat in HIV patients with lipodystrophy, together with Ipamorelin, a growth hormone-releasing peptide, can enhance overall body composition improvements. Furthermore, both substances may work synergistically to boost muscle growth, fat loss, recovery, and anti-aging effects, maximizing the benefits of each peptide when used in tandem. Before taking this medicine You should not use tesamorelin if you are allergic to it, or if you have: cancer; a pituitary gland disorder; a history of pituitary gland tumor or surgery; a history of head injury or radiation treatment; or if you are pregnant. To make sure you can safely take tesamorelin, tell your doctor if you have any of these other conditions: a history of cancer or any tumor (either benign or malignant); heart disease, high blood pressure; kidney disease; diabetes, eye problems caused by diabetes; epilepsy asthma; migraine headaches; adrenal gland disorder; if you have ever had open heart surgery; or if you have any major illness, a recent trauma, or a medical emergency. FDA pregnancy category X. This medication can harm an unborn baby or cause birth defects. Do not use tesamorelin if you are pregnant. Tell your doctor right away if you become pregnant during treatment. Women with HIV or AIDS should not breastfeed a baby. Even if your baby is born without HIV, the virus may be passed to the baby in your breast milk. WE EXPORT IN USA WE EXPORT IN UK WE EXPORT IN AUSTRALIA WE EXPORT IN CANADA WE EXPORT IN SINGAPORE